首页 > 最新文献

Pneumonologia i alergologia polska最新文献

英文 中文
[Systemic mastocytosis]. (系统性肥大细胞增多症)。
Pub Date : 2020-01-01 DOI: 10.1016/s0953-6205(11)60381-6
M. Niedoszytko, M. Lange, M. Chełmińska, K. Jaśkiewicz, Anna Piskosz, B. Wasąg, K. Lewandowski, A. Mital, J. Renke, M. Gruchała-Niedoszytko, M. Wozniak, A. Babińska, E. Jassem
{"title":"[Systemic mastocytosis].","authors":"M. Niedoszytko, M. Lange, M. Chełmińska, K. Jaśkiewicz, Anna Piskosz, B. Wasąg, K. Lewandowski, A. Mital, J. Renke, M. Gruchała-Niedoszytko, M. Wozniak, A. Babińska, E. Jassem","doi":"10.1016/s0953-6205(11)60381-6","DOIUrl":"https://doi.org/10.1016/s0953-6205(11)60381-6","url":null,"abstract":"","PeriodicalId":20258,"journal":{"name":"Pneumonologia i alergologia polska","volume":"73 3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/s0953-6205(11)60381-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56545971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of life in adults with cystic fibrosis: the Greek experience. 囊性纤维化成人的生活质量:希腊经验。
Pub Date : 2016-01-01 DOI: 10.5603/PiAP.2016.0025
Maria Stofa, Theodoros Xanthos, Konstantinos Ekmektzoglou, Athanasios Chalkias, Dimitrios Barouxis, Ioannis Pantazopoulos, Nicoletta Iacovidou

Introduction: Recent developments in treatment have steadily raised the median predicted age of survival for people with Cystic Fibrosis (CF). We report the health-related quality of life (HRQoL) in CF adult patients and correlate our findings with the patients' demographic characteristics.

Material and methods: The Cystic Fibrosis Quality of Life (CFQoL) questionnaire was answered by 77 CF adult patients. The questionnaire included questions pertaining to age, sex and level of education and covered eight sections of functioning.

Results: The highest score was reported in the "Social Functioning" section, while the lowest in the "Concerns for the Future" section. When different age groups were compared, statistical significances were reported in "Physical Functioning", "Interpersonal Relationships", and the "Career Concerns" section, with older patients reporting statistically higher HRQoL scores than younger ones (p < 0.005). No statistically significant difference was reported amongst the scoring between male and female CF patients. When different educational levels were compared, patients that had received a higher educational training scored statistically higher in all but one sections of the questionnaire when compared with patients of a lower educational level (p < 0.005).

Conclusion: More than half Greek adult CF patients report that they are capable to participate in social activities but most of them are worried about the outcome of their disease and its effect on their lives.

导言:最近的治疗进展稳步提高了囊性纤维化(CF)患者的中位预测生存年龄。我们报告了CF成年患者的健康相关生活质量(HRQoL),并将我们的发现与患者的人口统计学特征联系起来。材料与方法:对77例成年CF患者进行囊性纤维化生活质量(CFQoL)问卷调查。调查表包括与年龄、性别和教育水平有关的问题,并涵盖八个功能部分。结果:“社会功能”部分得分最高,“对未来的关注”部分得分最低。不同年龄组比较,“身体功能”、“人际关系”、“职业关注”三项HRQoL得分均有统计学意义,老年患者HRQoL得分高于年轻患者(p < 0.005)。男性和女性CF患者的评分无统计学差异。在不同文化程度的比较中,接受过高等教育培训的患者在问卷的所有部分得分均高于受教育程度较低的患者(p < 0.005)。结论:超过一半的希腊成年CF患者报告他们有能力参加社会活动,但他们中的大多数人担心他们的疾病的结果及其对他们生活的影响。
{"title":"Quality of life in adults with cystic fibrosis: the Greek experience.","authors":"Maria Stofa,&nbsp;Theodoros Xanthos,&nbsp;Konstantinos Ekmektzoglou,&nbsp;Athanasios Chalkias,&nbsp;Dimitrios Barouxis,&nbsp;Ioannis Pantazopoulos,&nbsp;Nicoletta Iacovidou","doi":"10.5603/PiAP.2016.0025","DOIUrl":"https://doi.org/10.5603/PiAP.2016.0025","url":null,"abstract":"<p><strong>Introduction: </strong>Recent developments in treatment have steadily raised the median predicted age of survival for people with Cystic Fibrosis (CF). We report the health-related quality of life (HRQoL) in CF adult patients and correlate our findings with the patients' demographic characteristics.</p><p><strong>Material and methods: </strong>The Cystic Fibrosis Quality of Life (CFQoL) questionnaire was answered by 77 CF adult patients. The questionnaire included questions pertaining to age, sex and level of education and covered eight sections of functioning.</p><p><strong>Results: </strong>The highest score was reported in the \"Social Functioning\" section, while the lowest in the \"Concerns for the Future\" section. When different age groups were compared, statistical significances were reported in \"Physical Functioning\", \"Interpersonal Relationships\", and the \"Career Concerns\" section, with older patients reporting statistically higher HRQoL scores than younger ones (p < 0.005). No statistically significant difference was reported amongst the scoring between male and female CF patients. When different educational levels were compared, patients that had received a higher educational training scored statistically higher in all but one sections of the questionnaire when compared with patients of a lower educational level (p < 0.005).</p><p><strong>Conclusion: </strong>More than half Greek adult CF patients report that they are capable to participate in social activities but most of them are worried about the outcome of their disease and its effect on their lives.</p>","PeriodicalId":20258,"journal":{"name":"Pneumonologia i alergologia polska","volume":"84 4","pages":"205-11"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34744225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Comorbidities in lung cancer. 肺癌的合并症
Pub Date : 2016-01-01 DOI: 10.5603/PiAP.2016.0022
Agata Ewa Dutkowska, Adam Antczak

Comorbidity is the occurrence of concomitant disease in addition to an index disease of interest or the simultaneous occurrence of multiple diseases in an individual. Lung cancer is associated with age and smoking, and both age and smoking are strongly associated with comorbidity. Lung cancer is the most common malignancy in the world. Comorbidity, such as diseases of cardiovascular, pulmonary and other systems may influence prognosis in lung cancer as well as complicate its treatment. In this paper we tried to conclude the significance of the individual comorbidities in lung cancer and their impact on particular treatment method.

共病是指除了感兴趣的指标疾病外,还伴有其他疾病的发生,或个体同时出现多种疾病。肺癌与年龄和吸烟有关,年龄和吸烟都与合并症密切相关。肺癌是世界上最常见的恶性肿瘤。合并症,如心血管、肺部和其他系统疾病,可能影响肺癌的预后,并使其治疗复杂化。在本文中,我们试图总结肺癌个体合并症的意义及其对特定治疗方法的影响。
{"title":"Comorbidities in lung cancer.","authors":"Agata Ewa Dutkowska,&nbsp;Adam Antczak","doi":"10.5603/PiAP.2016.0022","DOIUrl":"https://doi.org/10.5603/PiAP.2016.0022","url":null,"abstract":"<p><p>Comorbidity is the occurrence of concomitant disease in addition to an index disease of interest or the simultaneous occurrence of multiple diseases in an individual. Lung cancer is associated with age and smoking, and both age and smoking are strongly associated with comorbidity. Lung cancer is the most common malignancy in the world. Comorbidity, such as diseases of cardiovascular, pulmonary and other systems may influence prognosis in lung cancer as well as complicate its treatment. In this paper we tried to conclude the significance of the individual comorbidities in lung cancer and their impact on particular treatment method. </p>","PeriodicalId":20258,"journal":{"name":"Pneumonologia i alergologia polska","volume":"84 3","pages":"186-92"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34527912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 45
The effect of omalizumab on eosinophilic inflammation of the respiratory tract in patients with allergic asthma. 奥玛珠单抗对过敏性哮喘患者呼吸道嗜酸性粒细胞炎症的影响。
Pub Date : 2016-01-01 DOI: 10.5603/PiAP.2016.0029
Izabela Kupryś-Lipińska, Katarzyna Molińska, Piotr Kuna

Bronchial asthma is characterised by high levels of immunoglobulin E (IgE) and overproduction of pro-inflammatory cytokines, including interleukins IL-4, IL-13 and IL-5 needed for, amongst other things, the production of IgE and the differentiation, maturation, migration and survival of eosinophils. Eosinophils are one of the most important cells in allergic inflammation. Their presence in tissue is linked to the persistence of inflammatory infiltrate, tissue damage and remodelling. Although these cells are very sensitive to corticosteroids, some asthmatic patients do not respond to high doses of these drugs, even when administered systemically. Transbronchial biopsies and bronchoalveolar lavage performed in patients with steroid-resistant asthma have demonstrated higher levels of eosinophils and Th2-type cytokines (IL-4 and IL-5) compared to steroid-sensitive patients. Clinical studies have confirmed that the very effective treatment in these cases is therapy with omalizumab - an anti-IgE monoclonal antibody. The paper discusses the efficacy of omalizumab in reducing eosinophil number in peripheral blood and in the airways of asthmatic patients based on basic, clinical, observational studies and case reports. The significance of omalizumab therapy in asthma control and mechanisms that regulate the effects of omalizumab on eosinophils are evaluated.

支气管哮喘的特点是高水平的免疫球蛋白E (IgE)和促炎细胞因子的过量产生,包括白细胞介素IL-4、IL-13和IL-5,这些都是产生IgE和嗜酸性粒细胞分化、成熟、迁移和存活所必需的。嗜酸性粒细胞是过敏性炎症的重要细胞之一。它们在组织中的存在与炎症浸润、组织损伤和重塑的持续存在有关。尽管这些细胞对皮质类固醇非常敏感,但一些哮喘患者对高剂量这些药物没有反应,即使是全身给药。类固醇抵抗性哮喘患者经支气管活检和支气管肺泡灌洗显示,与类固醇敏感患者相比,嗜酸性粒细胞和th2型细胞因子(IL-4和IL-5)水平更高。临床研究已经证实,在这些病例中非常有效的治疗方法是使用omalizumab——一种抗ige单克隆抗体。本文结合基础研究、临床研究、观察性研究和病例报告,探讨omalizumab在降低哮喘患者外周血和气道嗜酸性粒细胞数量方面的疗效。评估了omalizumab治疗在哮喘控制中的意义以及调节omalizumab对嗜酸性粒细胞影响的机制。
{"title":"The effect of omalizumab on eosinophilic inflammation of the respiratory tract in patients with allergic asthma.","authors":"Izabela Kupryś-Lipińska,&nbsp;Katarzyna Molińska,&nbsp;Piotr Kuna","doi":"10.5603/PiAP.2016.0029","DOIUrl":"https://doi.org/10.5603/PiAP.2016.0029","url":null,"abstract":"<p><p>Bronchial asthma is characterised by high levels of immunoglobulin E (IgE) and overproduction of pro-inflammatory cytokines, including interleukins IL-4, IL-13 and IL-5 needed for, amongst other things, the production of IgE and the differentiation, maturation, migration and survival of eosinophils. Eosinophils are one of the most important cells in allergic inflammation. Their presence in tissue is linked to the persistence of inflammatory infiltrate, tissue damage and remodelling. Although these cells are very sensitive to corticosteroids, some asthmatic patients do not respond to high doses of these drugs, even when administered systemically. Transbronchial biopsies and bronchoalveolar lavage performed in patients with steroid-resistant asthma have demonstrated higher levels of eosinophils and Th2-type cytokines (IL-4 and IL-5) compared to steroid-sensitive patients. Clinical studies have confirmed that the very effective treatment in these cases is therapy with omalizumab - an anti-IgE monoclonal antibody. The paper discusses the efficacy of omalizumab in reducing eosinophil number in peripheral blood and in the airways of asthmatic patients based on basic, clinical, observational studies and case reports. The significance of omalizumab therapy in asthma control and mechanisms that regulate the effects of omalizumab on eosinophils are evaluated. </p>","PeriodicalId":20258,"journal":{"name":"Pneumonologia i alergologia polska","volume":"84 4","pages":"232-43"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34744229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 25
Lifestyle factors and asthma in India - a case-control study. 印度生活方式因素与哮喘——一项病例对照研究。
Pub Date : 2016-01-01 DOI: 10.5603/PiAP.2016.0008
Mohammed Noufal Poongadan, Nitesh Gupta, Raj Kumar

Introduction: There has been a recent trend of increasing prevalence of asthma in developing countries; prevalence in the Indian population is reported to be 2%. The link between lifestyle factors and asthma has been mostly derived from western literature. The present study intended to study relationship if any, between life style factors and asthma in a representative Indian population.

Material and methods: The study is a case-control study performed for a period of one year, between 2014 and 2015. 125 asthma and correspondingly age and sex matched healthy controls were recruited for the purpose of study. A self-reported questionnaire has been prepared based on routine lifestyle habits of Indian population.

Results: The hours of TV watching and hours of sleep were significantly higher in asthma patients, and also duration of sports activity showed inverse relation with asthma. Smoking, tobacco, chewing as well as alcohol consumption were higher in asthma patients in comparison to controls, though neither was statistically significant. The mental stress as assessed on scale of 1-10, was significantly higher in asthma patients (p < 0.001). Asthma patients had significantly lower travel duration/week (p < 0.05).

Conclusion: The present study concluded increased TV watching, increased mental stress, reduced hours of physical activity and travel may be correlated with asthma in India. With growing evidence of increasing association of asthma and sedentary lifestyle, it is imperative to reduce acquaintance to as well as incidence of these factors through public health policies, which may impact prevalence of asthma in Indian population.

最近发展中国家的哮喘患病率呈上升趋势;据报道,印度人口的患病率为2%。生活方式因素与哮喘之间的联系主要来自西方文献。本研究旨在研究有代表性的印度人群中生活方式因素与哮喘之间的关系。材料与方法:本研究为病例对照研究,时间为2014 - 2015年,为期一年。为了研究的目的,我们招募了125名哮喘患者以及相应年龄和性别匹配的健康对照。根据印度人的日常生活习惯,编制了一份自我报告问卷。结果:哮喘患者看电视时数、睡眠时数显著增高,运动时间与哮喘呈负相关。与对照组相比,哮喘患者吸烟、吸烟、咀嚼和饮酒的比例更高,尽管两者都没有统计学意义。以1-10量表评估,哮喘患者的精神压力显著高于对照组(p < 0.001)。哮喘患者的旅行时间明显低于对照组(p < 0.05)。结论:目前的研究得出结论,在印度,看电视时间的增加、精神压力的增加、体育活动时间的减少和旅行的减少可能与哮喘有关。随着越来越多的证据表明哮喘与久坐不动的生活方式之间的关联越来越大,有必要通过公共卫生政策来减少对这些因素的认识和发生率,这可能会影响印度人群中哮喘的患病率。
{"title":"Lifestyle factors and asthma in India - a case-control study.","authors":"Mohammed Noufal Poongadan,&nbsp;Nitesh Gupta,&nbsp;Raj Kumar","doi":"10.5603/PiAP.2016.0008","DOIUrl":"https://doi.org/10.5603/PiAP.2016.0008","url":null,"abstract":"<p><strong>Introduction: </strong>There has been a recent trend of increasing prevalence of asthma in developing countries; prevalence in the Indian population is reported to be 2%. The link between lifestyle factors and asthma has been mostly derived from western literature. The present study intended to study relationship if any, between life style factors and asthma in a representative Indian population.</p><p><strong>Material and methods: </strong>The study is a case-control study performed for a period of one year, between 2014 and 2015. 125 asthma and correspondingly age and sex matched healthy controls were recruited for the purpose of study. A self-reported questionnaire has been prepared based on routine lifestyle habits of Indian population.</p><p><strong>Results: </strong>The hours of TV watching and hours of sleep were significantly higher in asthma patients, and also duration of sports activity showed inverse relation with asthma. Smoking, tobacco, chewing as well as alcohol consumption were higher in asthma patients in comparison to controls, though neither was statistically significant. The mental stress as assessed on scale of 1-10, was significantly higher in asthma patients (p < 0.001). Asthma patients had significantly lower travel duration/week (p < 0.05).</p><p><strong>Conclusion: </strong>The present study concluded increased TV watching, increased mental stress, reduced hours of physical activity and travel may be correlated with asthma in India. With growing evidence of increasing association of asthma and sedentary lifestyle, it is imperative to reduce acquaintance to as well as incidence of these factors through public health policies, which may impact prevalence of asthma in Indian population.</p>","PeriodicalId":20258,"journal":{"name":"Pneumonologia i alergologia polska","volume":"84 2","pages":"104-8"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34593420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Diffuse Idiopathic Skeletal Hyperostosis (DISH) and non small cell lung cancer: case presentation and review of the literature. 弥漫性特发性骨骼增生症(DISH)和非小细胞肺癌:病例报告和文献回顾。
Pub Date : 2016-01-01 DOI: 10.5603/PiAP.2016.0010
Ioannis Tomos, Aikaterini Vlami, Anna Karakatsani, Ioanna Korbila, Effrosyni D Manali, Spyros A Papiris

Diffuse idiopathic skeletal hyperostosis (DISH), also known as Forestier's disease, is a systemic non inflammatory disease of unknown cause. It is characterized by the presence of osteophytes due to calcification and ossification of spinal ligaments and entheses. Moreover, diffuse idiopathic skeletal hyperostosis has been associated with a variety of metabolic disorders. However, to the best of our knowledge no association with non small cell lung cancer (NSCLC) has been reported so far. In the present study we report a case of a patient with NSCLC and DISH.

弥漫性特发性骨骼肥厚症(DISH),又称佛赖斯捷病,是一种病因不明的全身性非炎性疾病。它的特点是由于脊柱韧带和椎体的钙化和骨化而出现骨赘。此外,弥漫性特发性骨骼肥厚症与多种代谢紊乱有关。然而,据我们所知,到目前为止还没有与非小细胞肺癌(NSCLC)相关的报道。在本研究中,我们报告一例非小细胞肺癌合并DISH的患者。
{"title":"Diffuse Idiopathic Skeletal Hyperostosis (DISH) and non small cell lung cancer: case presentation and review of the literature.","authors":"Ioannis Tomos,&nbsp;Aikaterini Vlami,&nbsp;Anna Karakatsani,&nbsp;Ioanna Korbila,&nbsp;Effrosyni D Manali,&nbsp;Spyros A Papiris","doi":"10.5603/PiAP.2016.0010","DOIUrl":"https://doi.org/10.5603/PiAP.2016.0010","url":null,"abstract":"<p><p>Diffuse idiopathic skeletal hyperostosis (DISH), also known as Forestier's disease, is a systemic non inflammatory disease of unknown cause. It is characterized by the presence of osteophytes due to calcification and ossification of spinal ligaments and entheses. Moreover, diffuse idiopathic skeletal hyperostosis has been associated with a variety of metabolic disorders. However, to the best of our knowledge no association with non small cell lung cancer (NSCLC) has been reported so far. In the present study we report a case of a patient with NSCLC and DISH. </p>","PeriodicalId":20258,"journal":{"name":"Pneumonologia i alergologia polska","volume":"84 2","pages":"116-8"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34593422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
The clinical differences of asthma in patients with molds allergy. 霉菌过敏患者哮喘的临床差异分析。
Pub Date : 2016-01-01 DOI: 10.5603/PiAP.2016.0005
Krzysztof Kołodziejczyk, Andrzej Bożek, Jerzy Jarząb, Radosław Gawlik

Introduction: Bronchial asthma is an increasing problem worldwide. The course of bronchial asthma is dependent on the type of inducing allergens. The differences between the clinical features of asthma in patients with monovalent allergies to molds and with other allergies were explored.

Material and methods: Randomly selected 1910 patients (924 women and 986 men) between 18-86 years in age were analyzed according to type of allergy and asthma. The diagnosis of asthma was confirmed on the basis of GINA criteria, physical examination and spirometry. Allergy diagnosis was confirmed on the basis of medical history, a positive skin prick test and the measurement of serum-specific IgE to inhalant allergens, using an extended profile of mold allergens.

Results: Patients with monovalent allergies to molds (4% of analyzed group) had significantly more frequent diagnoses of asthma than patients in the other group (53% vs. 27.1-32.4%, p < 0.05). Patients with allergies to Alternaria alternata had an odds ratio of 2.11 (95%CI: 1.86-2.32) for receiving a diagnosis of bronchial asthma. They had less control over their asthma, which was more severe compared to patients with other allergies. Patients with asthma and allergies to mold had significantly more frequent exacerbation of asthma requiring systemic corticosteroids and/or hospitalization. They used a significantly greater mean daily dose of inhaled steroids compared to other patients.

Conclusion: Patients with monovalent IgE allergies to molds are at a higher risk for asthma than patients with other allergies. Their asthma is often more intense and less controlled compared to that of patients with other types of allergies.

支气管哮喘是一个日益严重的世界性问题。支气管哮喘的病程取决于诱发过敏原的类型。探讨单价霉菌过敏与其他过敏患者哮喘临床特征的差异。材料与方法:随机选取年龄在18 ~ 86岁的患者1910例(女性924例,男性986例),根据过敏和哮喘类型进行分析。根据GINA标准、体格检查和肺活量测定确定哮喘诊断。根据病史、阳性皮肤点刺试验和对吸入性过敏原的血清特异性IgE测定,使用扩展的霉菌过敏原谱,确认过敏诊断。结果:对霉菌单价过敏的患者(占分析组的4%)诊断哮喘的频率明显高于其他组(53%比27.1-32.4%,p < 0.05)。对交替菌过敏的患者接受支气管哮喘诊断的优势比为2.11 (95%CI: 1.86-2.32)。他们对哮喘的控制较少,与其他过敏症患者相比,哮喘更为严重。哮喘和霉菌过敏的患者有明显更频繁的哮喘恶化,需要全身皮质类固醇和/或住院治疗。与其他患者相比,他们吸入类固醇的平均日剂量明显更高。结论:霉菌单价IgE过敏患者发生哮喘的风险高于其他过敏患者。与其他类型的过敏患者相比,他们的哮喘往往更严重,更不受控制。
{"title":"The clinical differences of asthma in patients with molds allergy.","authors":"Krzysztof Kołodziejczyk,&nbsp;Andrzej Bożek,&nbsp;Jerzy Jarząb,&nbsp;Radosław Gawlik","doi":"10.5603/PiAP.2016.0005","DOIUrl":"https://doi.org/10.5603/PiAP.2016.0005","url":null,"abstract":"<p><strong>Introduction: </strong>Bronchial asthma is an increasing problem worldwide. The course of bronchial asthma is dependent on the type of inducing allergens. The differences between the clinical features of asthma in patients with monovalent allergies to molds and with other allergies were explored.</p><p><strong>Material and methods: </strong>Randomly selected 1910 patients (924 women and 986 men) between 18-86 years in age were analyzed according to type of allergy and asthma. The diagnosis of asthma was confirmed on the basis of GINA criteria, physical examination and spirometry. Allergy diagnosis was confirmed on the basis of medical history, a positive skin prick test and the measurement of serum-specific IgE to inhalant allergens, using an extended profile of mold allergens.</p><p><strong>Results: </strong>Patients with monovalent allergies to molds (4% of analyzed group) had significantly more frequent diagnoses of asthma than patients in the other group (53% vs. 27.1-32.4%, p < 0.05). Patients with allergies to Alternaria alternata had an odds ratio of 2.11 (95%CI: 1.86-2.32) for receiving a diagnosis of bronchial asthma. They had less control over their asthma, which was more severe compared to patients with other allergies. Patients with asthma and allergies to mold had significantly more frequent exacerbation of asthma requiring systemic corticosteroids and/or hospitalization. They used a significantly greater mean daily dose of inhaled steroids compared to other patients.</p><p><strong>Conclusion: </strong>Patients with monovalent IgE allergies to molds are at a higher risk for asthma than patients with other allergies. Their asthma is often more intense and less controlled compared to that of patients with other types of allergies.</p>","PeriodicalId":20258,"journal":{"name":"Pneumonologia i alergologia polska","volume":"84 2","pages":"81-6"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34434787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
The pharmaceutical care in asthma - Polish and global perspective. 哮喘的药物治疗-波兰和全球视角。
Pub Date : 2016-01-01 DOI: 10.5603/PiAP.2016.0028
Damian Swieczkowski, Patryk Poniatowski, Piotr Merks, Milosz Jaguszewski

The pharmaceutical care is a pharmacist's contribution to the care of individual patients and leads to optimize the use of drugs. The pharmaceutical care may improve adherence, clinical effectiveness of providing therapy and improve the health-related quality of life. The conducted literature review confirmed that pharmaceutical care and advanced pharmaceutical services are clinical effective in asthma. The implementation of pharmaceutical care under Polish conditions is currently insufficient and remains challenging for the future. Herein we should admit, that the polish government has recently put an effort to appoint specially dedicated team establishing a program of reimbursed pharmaceutical care. This move should be considered as a new phase for amendments community pharmacy in Poland. The experience of different health care systems, including for instance United Kingdom, Australia or Canada, might be used in the process of changing Polish perspective. Herein, we have reviewed the literature and highlighted the services creating the program of pharmaceutical care in asthma. This unique work describes the complex nature of optimal pharmaceutical services emphasizing the strong necessity of multidimensional approach in this field.

药学服务是药剂师对个体患者护理的贡献,并导致药物的优化使用。药物治疗可提高患者的依从性,提高治疗的临床效果,改善与健康相关的生活质量。通过文献综述,证实药学服务和先进的药学服务对哮喘的临床治疗是有效的。在波兰的条件下实施药物护理目前是不足的,未来仍然具有挑战性。在此,我们应该承认,波兰政府最近已经努力任命了一个专门的团队,建立了一个报销的药物保健计划。这一举措应被视为修订波兰社区药房的新阶段。不同卫生保健系统的经验,包括例如英国、澳大利亚或加拿大,可以用于改变波兰观点的过程中。在此,我们回顾了文献并强调了在哮喘中创建药物护理计划的服务。这项独特的工作描述了最佳药物服务的复杂性,强调了在该领域采用多维方法的强烈必要性。
{"title":"The pharmaceutical care in asthma - Polish and global perspective.","authors":"Damian Swieczkowski,&nbsp;Patryk Poniatowski,&nbsp;Piotr Merks,&nbsp;Milosz Jaguszewski","doi":"10.5603/PiAP.2016.0028","DOIUrl":"https://doi.org/10.5603/PiAP.2016.0028","url":null,"abstract":"<p><p>The pharmaceutical care is a pharmacist's contribution to the care of individual patients and leads to optimize the use of drugs. The pharmaceutical care may improve adherence, clinical effectiveness of providing therapy and improve the health-related quality of life. The conducted literature review confirmed that pharmaceutical care and advanced pharmaceutical services are clinical effective in asthma. The implementation of pharmaceutical care under Polish conditions is currently insufficient and remains challenging for the future. Herein we should admit, that the polish government has recently put an effort to appoint specially dedicated team establishing a program of reimbursed pharmaceutical care. This move should be considered as a new phase for amendments community pharmacy in Poland. The experience of different health care systems, including for instance United Kingdom, Australia or Canada, might be used in the process of changing Polish perspective. Herein, we have reviewed the literature and highlighted the services creating the program of pharmaceutical care in asthma. This unique work describes the complex nature of optimal pharmaceutical services emphasizing the strong necessity of multidimensional approach in this field. </p>","PeriodicalId":20258,"journal":{"name":"Pneumonologia i alergologia polska","volume":"84 4","pages":"225-31"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34744228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Fungal infection of cystic fibrosis patients - single center experience. 囊性纤维化患者真菌感染-单中心经验。
Pub Date : 2016-01-01 DOI: 10.5603/PiAP.2016.0017
Barbara Garczewska, Sylwia Jarzynka, Jan Kuś, Wojciech Skorupa, Ewa Augustynowicz-Kopeć

Introduction: Cystic fibrosis (CF) is the most common monogenetic autosomal recessive disease in the human population. This systemic disease is characterized by changes in multiple organs, mainly in the lung tissue and digestive tract. More than 59% of CF patients become sensitized to fungal spores, mostly Aspergillus fumigatus. 5-15% of CF patients develop allergic bronchopulmonary aspergillosis. The aim of the study was to analyse the occurrence of yeast and filamentous fungi of the respiratory infections in CF patients and evaluation of drug resistance.

Material and methods: Between 2006 and 2014, mycological evaluation of 42 patients hospitalized at the National Institute of Tuberculosis and Lung Diseases was carried out.

Results: 217 specimens from pulmonary tract were collected from 42 patients with cystic fibrosis. 205 (68%) strains of yeast and 96 (32%) filamentous fungi strains were cultured. The most common mould strain was A. fumigatus - 22,2% (67 species). All isolates of filamentous fungi were in vitro 100% susceptible to itraconazole, voriconazole, posaconazole and amphotericin B.

Conclusions: A. fumigatus and C. albicans were the most common etiological agents of fungal respiratory pathogens associated with CF patients. A. fumigatus strains were in vitro 100% susceptible to azole and amphotericin B. Two strains of C. albicans and one strain of C. tropicalis were non-susceptible to azole (fluconazole, itraconazole and voriconazole). Scedosporium apiospermum was resistant to amphotericin B (MIC > 32 mg/l) and susceptible to voriconazole (MIC 0.094 mg/l).

简介:囊性纤维化(CF)是人类最常见的单基因常染色体隐性遗传病。这种全身性疾病的特点是多器官发生变化,主要发生在肺组织和消化道。超过59%的CF患者对真菌孢子敏感,主要是烟曲霉。5-15%的CF患者发生过敏性支气管肺曲菌病。本研究的目的是分析CF患者呼吸道感染的酵母菌和丝状真菌的发生情况及耐药性评价。材料和方法:2006年至2014年,对42名在国家结核病和肺病研究所住院的患者进行真菌学评估。结果:42例囊性纤维化患者共采集肺标本217份。培养205株(68%)酵母菌和96株(32%)丝状真菌。最常见的霉菌菌株为烟曲霉(A. fumigatus),占22.2%(67种)。丝状真菌对伊曲康唑、伏立康唑、泊沙康唑和两性霉素b的体外敏感性均为100%。结论:CF患者呼吸道真菌致病菌以烟曲霉属和白色念珠菌最为常见。烟曲霉体外对唑类和两性霉素b均100%敏感,2株白色假丝酵母菌和1株热带假丝酵母菌对氟康唑、伊曲康唑和伏立康唑不敏感。对两性霉素B (MIC > 32 mg/l)耐药,对伏立康唑(MIC 0.094 mg/l)敏感。
{"title":"Fungal infection of cystic fibrosis patients - single center experience.","authors":"Barbara Garczewska,&nbsp;Sylwia Jarzynka,&nbsp;Jan Kuś,&nbsp;Wojciech Skorupa,&nbsp;Ewa Augustynowicz-Kopeć","doi":"10.5603/PiAP.2016.0017","DOIUrl":"https://doi.org/10.5603/PiAP.2016.0017","url":null,"abstract":"<p><strong>Introduction: </strong>Cystic fibrosis (CF) is the most common monogenetic autosomal recessive disease in the human population. This systemic disease is characterized by changes in multiple organs, mainly in the lung tissue and digestive tract. More than 59% of CF patients become sensitized to fungal spores, mostly Aspergillus fumigatus. 5-15% of CF patients develop allergic bronchopulmonary aspergillosis. The aim of the study was to analyse the occurrence of yeast and filamentous fungi of the respiratory infections in CF patients and evaluation of drug resistance.</p><p><strong>Material and methods: </strong>Between 2006 and 2014, mycological evaluation of 42 patients hospitalized at the National Institute of Tuberculosis and Lung Diseases was carried out.</p><p><strong>Results: </strong>217 specimens from pulmonary tract were collected from 42 patients with cystic fibrosis. 205 (68%) strains of yeast and 96 (32%) filamentous fungi strains were cultured. The most common mould strain was A. fumigatus - 22,2% (67 species). All isolates of filamentous fungi were in vitro 100% susceptible to itraconazole, voriconazole, posaconazole and amphotericin B.</p><p><strong>Conclusions: </strong>A. fumigatus and C. albicans were the most common etiological agents of fungal respiratory pathogens associated with CF patients. A. fumigatus strains were in vitro 100% susceptible to azole and amphotericin B. Two strains of C. albicans and one strain of C. tropicalis were non-susceptible to azole (fluconazole, itraconazole and voriconazole). Scedosporium apiospermum was resistant to amphotericin B (MIC > 32 mg/l) and susceptible to voriconazole (MIC 0.094 mg/l).</p>","PeriodicalId":20258,"journal":{"name":"Pneumonologia i alergologia polska","volume":"84 3","pages":"151-9"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34527907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Association of interleukins genes polymorphisms with multi-drug resistant tuberculosis in Ukrainian population. 乌克兰人群中白细胞介素基因多态性与多重耐药结核病的关系
Pub Date : 2016-01-01 DOI: 10.5603/PiAP.2016.0019
Dmytro O Butov, Mykhaylo M Kuzhko, Natalia I Makeeva, Tetyana S Butova, Hanna L Stepanenko, Andrii B Dudnyk

Introduction: Multi-drug resistant tuberculosis (MDR TB) is a significant health problem in some parts of the world. Three major cytokines involved in TB immunopathogenesis include IL-2, IL-4 and IL-10. The susceptibility to MDR TB may be genetically determined. The aim of the study was to assess the association of IL-2, IL-4, IL-10 gene polymorphisms with multi-drug resistant tuberculosis (MDR TB) in Ukrainian population.

Material and methods: We observed 140 patients suffering from infiltrative pulmonary tuberculosis (PT) and 30 apparently healthy subjects. The patients were assigned to two groups whether they suffer or do not suffer from pulmonary MDR TB. Interleukin gene (IL) polymorphisms, particularly T330G polymorphism in the IL-2 gene, C589T polymorphism in the IL-4 gene and G1082A polymorphism in the IL-10 gene were studied through polymerase chain reaction. Circulating levels of IL-2, IL-4 and IL-10 in venous blood were estimated using ELISA.

Results: Prior to treatment, patients with PT showed significant increase of IL-2 levels and decrease of IL-4 and IL-10 levels compared to apparently healthy subjects. Circulating IL-4 and IL-10 levels were significantly decreased whilst serum IL-2 level was significantly increased in patients with MDR TB compared to non-MDR TB. Low IL-4 and IL-10 secretion and considerable IL-2 alterations were shown to be significantly associated with mutations of homozygous and heterozygous genotypes affecting C589T polymorphism in the IL-4 gene, G1082A polymorphism in the IL-10 gene and T330G polymorphism in the IL-2 gene in patients with PT.

Conclusions: Heterozygous genotype and mutations homozygous genotypes gene in polymorphisms determining specified cytokines' production is a PT risk factor and may lead to disease progression into chronic phase. Heterozygous genotype of aforementioned cytokine genetic polymorphisms was significantly the most frequent in patients with MDR TB.

导言:耐多药结核病(MDR TB)是世界上一些地区的一个重大卫生问题。参与TB免疫发病的三种主要细胞因子包括IL-2、IL-4和IL-10。对耐多药结核病的易感性可能由基因决定。该研究的目的是评估乌克兰人群中IL-2、IL-4、IL-10基因多态性与耐多药结核病(MDR TB)的关系。材料与方法:观察140例浸润性肺结核(PT)患者和30例表面健康者。无论患者是否患有肺部耐多药结核病,患者被分为两组。通过聚合酶链反应研究白细胞介素基因(IL)多态性,特别是IL-2基因的T330G多态性、IL-4基因的C589T多态性和IL-10基因的G1082A多态性。采用ELISA法测定静脉血中IL-2、IL-4、IL-10的循环水平。结果:治疗前,PT患者IL-2水平较明显升高,IL-4、IL-10水平较明显降低。与非耐多药结核病患者相比,耐多药结核病患者循环IL-4和IL-10水平显著降低,血清IL-2水平显著升高。IL-4和IL-10的低分泌和IL-2的显著改变与纯合子和杂合子基因型突变显著相关,影响pt患者IL-4基因C589T多态性、IL-10基因G1082A多态性和IL-2基因T330G多态性。杂合子基因型和突变纯合子基因型基因多态性决定特定细胞因子的产生是PT的危险因素,可能导致疾病进展为慢性期。上述细胞因子遗传多态性的杂合子基因型在耐多药结核病患者中最为常见。
{"title":"Association of interleukins genes polymorphisms with multi-drug resistant tuberculosis in Ukrainian population.","authors":"Dmytro O Butov,&nbsp;Mykhaylo M Kuzhko,&nbsp;Natalia I Makeeva,&nbsp;Tetyana S Butova,&nbsp;Hanna L Stepanenko,&nbsp;Andrii B Dudnyk","doi":"10.5603/PiAP.2016.0019","DOIUrl":"https://doi.org/10.5603/PiAP.2016.0019","url":null,"abstract":"<p><strong>Introduction: </strong>Multi-drug resistant tuberculosis (MDR TB) is a significant health problem in some parts of the world. Three major cytokines involved in TB immunopathogenesis include IL-2, IL-4 and IL-10. The susceptibility to MDR TB may be genetically determined. The aim of the study was to assess the association of IL-2, IL-4, IL-10 gene polymorphisms with multi-drug resistant tuberculosis (MDR TB) in Ukrainian population.</p><p><strong>Material and methods: </strong>We observed 140 patients suffering from infiltrative pulmonary tuberculosis (PT) and 30 apparently healthy subjects. The patients were assigned to two groups whether they suffer or do not suffer from pulmonary MDR TB. Interleukin gene (IL) polymorphisms, particularly T330G polymorphism in the IL-2 gene, C589T polymorphism in the IL-4 gene and G1082A polymorphism in the IL-10 gene were studied through polymerase chain reaction. Circulating levels of IL-2, IL-4 and IL-10 in venous blood were estimated using ELISA.</p><p><strong>Results: </strong>Prior to treatment, patients with PT showed significant increase of IL-2 levels and decrease of IL-4 and IL-10 levels compared to apparently healthy subjects. Circulating IL-4 and IL-10 levels were significantly decreased whilst serum IL-2 level was significantly increased in patients with MDR TB compared to non-MDR TB. Low IL-4 and IL-10 secretion and considerable IL-2 alterations were shown to be significantly associated with mutations of homozygous and heterozygous genotypes affecting C589T polymorphism in the IL-4 gene, G1082A polymorphism in the IL-10 gene and T330G polymorphism in the IL-2 gene in patients with PT.</p><p><strong>Conclusions: </strong>Heterozygous genotype and mutations homozygous genotypes gene in polymorphisms determining specified cytokines' production is a PT risk factor and may lead to disease progression into chronic phase. Heterozygous genotype of aforementioned cytokine genetic polymorphisms was significantly the most frequent in patients with MDR TB.</p>","PeriodicalId":20258,"journal":{"name":"Pneumonologia i alergologia polska","volume":"84 3","pages":"168-73"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34527909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
期刊
Pneumonologia i alergologia polska
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1